BT9 is a novel small molecule that binds to MAGMAS and potentially blocks protein trafficking across the inner membrane, and it has shown inhibitory effects on proliferation and migration in glioblastoma and prostate cancer cell lines [19,29]. Here, PAM16 is linked to prostate carcinoma.